Bleomycin in germ cell tumor therapy: Not all regimens are created equal

被引：13

作者：

Bajorin, DF

Bosl, GJ

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1997年 / 15卷 / 05期

关键词：

D O I：

10.1200/JCO.1997.15.5.1717

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1717 / 1719

页数：3

相关论文

共 11 条

[1] COMPARISON OF CRITERIA FOR ASSIGNING GERM-CELL TUMOR PATIENTS TO GOOD RISK AND POOR RISK STUDIES
BAJORIN, D
KATZ, A
CHAN, E
GELLER, N
VOGELZANG, N
BOSL, GJ
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (05) : 786 - 792
[2] RANDOMIZED TRIAL OF ETOPOSIDE AND CISPLATIN VERSUS ETOPOSIDE AND CARBOPLATIN IN PATIENTS WITH GOOD-RISK GERM-CELL TUMORS - A MULTIINSTITUTIONAL STUDY
BAJORIN, DF
SAROSDY, MF
PFISTER, DG
MAZUMDAR, M
MOTZER, RJ
SCHER, HI
GELLER, NL
FAIR, WR
HERR, H
SOGANI, P
SHEINFELD, J
RUSSO, P
VLAMIS, V
CAREY, R
VOGELZANG, NJ
CRAWFORD, ED
BOSL, GJ
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) : 598 - 606
[3] Bosl George J., 1997, P1397
[4] A RANDOMIZED TRIAL OF ETOPOSIDE + CISPLATIN VERSUS VINBLASTINE + BLEOMYCIN + CISPLATIN + CYCLOPHOSPHAMIDE + DACTINOMYCIN IN PATIENTS WITH GOOD-PROGNOSIS GERM-CELL TUMORS
BOSL, GJ
GELLER, NL
BAJORIN, D
LEITNER, SP
YAGODA, A
GOLBEY, RB
SCHER, H
VOGELZANG, NJ
AUMAN, J
CAREY, R
FAIR, WR
HERR, H
MORSE, M
SOGANI, P
WHITMORE, W
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (08) : 1231 - 1238
[5] Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group
deWit, R
Stoter, G
Kaye, SB
Sleijfer, DT
Jones, WG
Huinink, WWT
Rea, LA
Collette, L
Sylvester, R
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 1837 - 1843
[6] EVALUATION OF OPTIMAL DURATION OF CHEMOTHERAPY IN FAVORABLE-PROGNOSIS DISSEMINATED GERM-CELL TUMORS - A SOUTHEASTERN-CANCER-STUDY-GROUP PROTOCOL
EINHORN, LH
WILLIAMS, SD
LOEHRER, PJ
BIRCH, R
DRASGA, R
OMURA, G
GRECO, FA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (03) : 387 - 391
[7] HORWICH A, 1984, ETOPOSIDE VP16 CURRE, P233
[8] HORWICH A, 1994, P AN M AM SOC CLIN, V13, P230
[9] *INT GERM CELL CAN, 1997, J CLIN ONCOL, V15, P594
[10] IMPORTANCE OF BLEOMYCIN IN FAVORABLE-PROGNOSIS DISSEMINATED GERM-CELL TUMORS - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP TRIAL
LOEHRER, PJ
JOHNSON, D
ELSON, P
EINHORN, LH
TRUMP, D
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (02) : 470 - 476